The insights gained from blood diagnostics also provide Hims and healthcare providers with a comprehensive picture of each patient's health status, enabling a holistic, individualized treatment plan with personalized medications, supplements, exercise programs, and nutrition
Not all individuals qualify for treatment, and treatment decisions are made solely by the evaluating provider
Each vial is prepared for laboratory handling and is intended for analytical, structural, and scientific research use only
Gilead recently completed its acquisition of Tubulis GmbH, a private Germany-based, biotechnology company developing next-gen antibody-drug conjugates (ADCs), for $3.15 billion upfront and up to $1.85 billion in contingent milestone payments
Indeed, a day-dependent variability has been reported for CYP3A gene expression and mediated metabolism of other several drugs (Tomalik-Scharte et al., 2014)
Ready to try tracking in a way that actually sticks?